North America Infectious Disease Point of Care Diagnostics Market was valued at USD 0.9 Billion in 2022 and is projected to reach USD 1.8 Billion by 2030, growing at a CAGR of 8.5% from 2024 to 2030.
In the rapidly evolving healthcare landscape, the North American infectious disease point-of-care (POC) diagnostics market has emerged as a pivotal player. With a valuation of approximately USD 17.53 billion in 2022, projections indicate a robust compound annual growth rate (CAGR) of 6.2%, anticipating the market to reach USD 28.46 billion by 2030. This growth trajectory underscores the increasing demand for swift and accurate diagnostic solutions.
Several factors contribute to this market expansion:
Rising Prevalence of Infectious Diseases: The resurgence of diseases like syphilis, which has seen an 80% increase in cases over the past five years in the U.S., highlights the pressing need for immediate and reliable diagnostic tools.
Technological Advancements: Innovations such as AI-assisted diagnostics are enhancing the speed and accuracy of disease identification, addressing challenges like the North America shortage of pathologists.
Regulatory Approvals: The FDA's authorization of over-the-counter tests, including the first at-home syphilis test, has expanded access to diagnostics, empowering individuals to take proactive measures regarding their health.
From an industry perspective, the requirements to thrive in this market are multifaceted:
Integration of Advanced Technologies: Companies are increasingly adopting AI and machine learning to improve diagnostic accuracy and efficiency. For instance, Dublin-based Deciphex has raised €31 million to enhance AI-assisted diagnostics, aiming to alleviate the North America shortage of pathologists by increasing productivity by up to 40%.
Regulatory Compliance: Navigating the complex landscape of healthcare regulations is crucial. Firms must ensure their products meet stringent standards set by authorities like the FDA to gain market entry and consumer trust.
Scalability and Accessibility: The ability to produce cost-effective, scalable solutions that can be easily deployed across diverse settings—from urban hospitals to remote clinics—is essential. This includes developing portable, user-friendly devices that deliver rapid results without compromising accuracy.
Reflecting on personal experiences, the integration of POC diagnostics in clinical practice has been transformative. In my tenure as a healthcare professional, the shift from traditional laboratory testing to immediate, bedside diagnostics has not only expedited patient care but also improved outcomes. The immediacy of POC testing allows for prompt decision-making, which is particularly crucial in managing infectious diseases where time is of the essence.
In conclusion, the North American infectious disease POC diagnostics market is poised for significant growth, driven by technological innovations, regulatory advancements, and an increasing emphasis on rapid, accurate disease detection. Industries that prioritize technological integration, adhere to regulatory standards, and focus on scalable solutions are well-positioned to meet the evolving demands of this dynamic market.
North America Infectious Disease Point of Care Diagnostics Market
Get an In-Depth Research Analysis of the North America Infectious Disease Point of Care Diagnostics Market Size And Forecast [2025-2032]
Abbott
Siemens
GE Healthcare
Accriva
Terumo
BioMerieux
Diasorin
Roche
Danaher Corporation
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
Euroimmun
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the North America Infectious Disease Point of Care Diagnostics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the North America Infectious Disease Point of Care Diagnostics Market
Bacterial Infections
Fungal Infection
Virus Infection
Cardiovascular Infection
Gastrointestinal Infection
Sexually Transmitted Disease (STD) Infection
Central Nervous System Infection
Other
Based on Types the Market is categorized into Below types that held the largest Infectious Disease Point of Care Diagnostics market share In 2023.
Over-the-counter (OTC) Testing Kits
Prescription-based Testing Kits
North America (United States, North America and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Infectious Disease Point of Care Diagnostics Market Research Analysis
1. Introduction of the North America Infectious Disease Point of Care Diagnostics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. North America Infectious Disease Point of Care Diagnostics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. North America Infectious Disease Point of Care Diagnostics Market, By Type
6. North America Infectious Disease Point of Care Diagnostics Market, By Application
7. North America Infectious Disease Point of Care Diagnostics Market, By Geography
North America
Europe
Asia Pacific
Rest of the World
8. North America Infectious Disease Point of Care Diagnostics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading North America Research and Consulting firm servicing over 5000+ North America clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/